Assessment of N-Acetylcysteine as Therapy for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome

NCT04542161 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

95

Enrollment

OTHER

Sponsor class

Conditions

Chronic Fatigue Syndrome
Myalgic Encephalomyelitis

Interventions

DRUG: NAC 900mg/day
DRUG: NAC 3600mg/day
DRUG: NAC 0mg/day (Placebo)

Sponsor

Weill Medical College of Cornell University

Collaborators

[object Object]